You appear to be using incognito/private browsing mode or an ad blocker, which may adversely affect your experience on the site. Please disable any ad blockers and view the site in non-private mode.
For in vitro diagnostic use. Others Elecsys CYFRA 21-1 IVD Elecsys® CYFRA 21-1 CPS_000462 07 299 966 190 7 299 966 190 07299966190 7299966190 07299966190 Cyfra 21-1 Elecsys E2G 300 Elecsys CYFRA 21-1 04015630940004 Reagents, kits 300 tests cobas e 402/801 true 11 820 966 122 11820966122 Cyfra 21-1 Elecsys cobas e 100 Elecsys CYFRA 21-1 04015630909827 Reagents, kits 100 tests cobas e 411/601/602 true 07299966500 Elecsys CYFRA 21-1 en 8 FF000000060EE70E FF0000000441620E 07299966190 07299966214 9494 cobas e 402 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of fragments of cytokeratin 19 in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 11820966500 Elecsys CYFRA 21-1 en 21 FF00000003E7BD0E FF00000000291D0E 11820966122 2325 cobas e 602 619 cobas e 601 618 cobas e 411 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of fragments of cytokeratin 19 in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 11820966500 Elecsys CYFRA 21-1 en 23 FF0000000552880E FF0000000552880E 11820966122 11820966188 11820966214 2325 cobas e 602 619 cobas e 601 618 cobas e 411 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunoassay for the in vitro quantitative determination of fragments of cytokeratin 19 in human serum and plasma.The electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en